Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral May/19/2021 26 7
Grazoprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/31/2021 4 1
Dacomitinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021 2 0
Famotidine Potential treatment - clinical evidence Used to treat other disease Unknown Mar/08/2021 2 3
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021 13 0
Paritaprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021 5 0
Δ9-Tetrahydrocannabinol Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Dec/05/2020 2 0
Simeprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/02/2020 9 1
Prednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/14/2020 4 0
Streptolydigin Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/02/2020 1 0